COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?
作者信息
Thangaraju Pugazhenthan, Gurunthalingam Meenalotchini Prakash, Venkatesan Sajitha, Thangaraju Eswaran
机构信息
Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India.
Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India.
出版信息
J Infect Public Health. 2020 Jun;13(6):899-900. doi: 10.1016/j.jiph.2020.05.006. Epub 2020 May 11.
Abstract
摘要
相似文献
1
COVID-19: Wait for a novel drug or act with the age old drug - Do we have a choice?新型冠状病毒肺炎（COVID-19）：等待新药还是使用古老药物——我们有选择吗？
J Infect Public Health. 2020 Jun;13(6):899-900. doi: 10.1016/j.jiph.2020.05.006. Epub 2020 May 11.
2
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
3
Chloroquine for COVID-19: rationale, facts, hopes.氯喹用于治疗新型冠状病毒肺炎：理论依据、事实与希望。
Crit Care. 2020 May 8;24(1):210. doi: 10.1186/s13054-020-02932-4.
4
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
5
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?在疟疾感染率较高的国家，2019冠状病毒病（COVID-19）的发病率是否较低？
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
6
World War against COVID-19: How strong is our armamentarium?抗击新冠疫情之战：我们的武器库有多强大？
Med J Malaysia. 2020 May;75(3):314-315.
7
Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.2019年冠状病毒病大流行：寄厚望于用已知药物对抗未知病毒
Indian J Pharmacol. 2020 Mar-Apr;52(2):75-78. doi: 10.4103/ijp.IJP_309_20. Epub 2020 Jun 3.
8
What is the role of rheumatologists in the era of COVID-19?在新冠疫情时代，风湿病学家的作用是什么？
Autoimmun Rev. 2020 Jun;19(6):102539. doi: 10.1016/j.autrev.2020.102539. Epub 2020 Apr 3.
9
Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.用于治疗新冠肺炎的氯喹/羟氯喹引发室性心律失常的风险：是否应该使用该药？
Indian Heart J. 2020 Mar-Apr;72(2):131-132. doi: 10.1016/j.ihj.2020.04.006. Epub 2020 Apr 27.
10
Critical Need for Implementation of Clinical Pharmacology Principles in Developing Drugs for the Treatment or Prevention of COVID-19.在开发用于治疗或预防新冠肺炎的药物时实施临床药理学原则的迫切需求。
J Clin Pharmacol. 2020 Aug;60(8):979. doi: 10.1002/jcph.1690. Epub 2020 Jul 5.
引用本文的文献
1
Lack of protective effect of chloroquine derivatives on COVID-19 disease in a Spanish sample of chronically treated patients.氯喹衍生物对西班牙慢性治疗患者样本中 COVID-19 疾病的无保护作用。
PLoS One. 2020 Dec 14;15(12):e0243598. doi: 10.1371/journal.pone.0243598. eCollection 2020.
2
Are We Jumping the Gun with Itolizumab in India? A Situational Analysis from the Pre-COVID Era.我们在印度使用依妥珠单抗是否操之过急？来自新冠疫情前时代的态势分析。
SN Compr Clin Med. 2020;2(11):2131-2136. doi: 10.1007/s42399-020-00550-3. Epub 2020 Sep 26.
本文引用的文献
1
[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].羟氯喹治疗中度新型冠状病毒肺炎患者的一项试点研究
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. doi: 10.3785/j.issn.1008-9292.2020.03.03.
2
Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use.洛匹那韦/利托那韦联合疗法用于印度有症状的 2019 冠状病毒病患者：限制公共卫生紧急使用的方案。
Indian J Med Res. 2020;151(2 & 3):184-189. doi: 10.4103/ijmr.IJMR_502_20.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19：一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.
4
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
5
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.新型冠状病毒在武汉持续爆发中的进化及其刺突蛋白对人类传播风险的建模。
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
6
An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease.评估氯喹对手足口病的广谱抗病毒作用。
Antiviral Res. 2018 Jan;149:143-149. doi: 10.1016/j.antiviral.2017.11.017. Epub 2017 Nov 22.
7
Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice.氯喹，一种美国食品药品监督管理局批准的药物，可预防寨卡病毒感染及其引起的小鼠先天性小头畸形。
EBioMedicine. 2017 Oct;24:189-194. doi: 10.1016/j.ebiom.2017.09.034. Epub 2017 Sep 28.
8
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model.抗疟疾药物氯喹在动物模型中对治疗甲型H5N1禽流感病毒感染非常有效。
Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.
9
Antiviral activity of chloroquine against human coronavirus OC43 infection in newborn mice.氯喹对新生小鼠人冠状病毒OC43感染的抗病毒活性
Antimicrob Agents Chemother. 2009 Aug;53(8):3416-21. doi: 10.1128/AAC.01509-08. Epub 2009 Jun 8.
10
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.氯喹是一种有效的严重急性呼吸综合征冠状病毒感染和传播抑制剂。
Virol J. 2005 Aug 22;2:69. doi: 10.1186/1743-422X-2-69.
Zotero 插件